KRAS and non-small cell lung carcinoma: AMG-510 (150 in Scheme 15, Table 1, entry 15) is an experimental KRAS inhibitor that is under study for the treatment of KRAS G12C mutant non-small cell lung cancer, colorectal cancer and appendix cancer.